The approval and success of powerful new cancer treatments such as CAR T-cell therapy are breeding optimism among companies, scientists and patients around the world.TD2 can help influence your trial design and get your drug on a faster path to approval.
The Trends Behind Successful Cancer Treatments
September 30, 2020
The Rise of Humanized Mouse Models in Oncology: What Drug Developers Need to Know
Traditional mouse models remain a cornerstone of preclinical oncology research. Syngeneic and xenografts mouse models continue to play a critical ...
Flow Cytometry User Groups And The Relaunch Of The NWFCS
By Jennifer J. Stewart, PhD
Live Dead Measurement and Cell Viability
By Marrisssa Bailey, BS
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.